These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28748768)

  • 1. Allosteric Targeting of Aurora A Kinase Using Small Molecules: A Step Forward Towards Next Generation Medicines?
    Panicker RC; Coyne AG; Srinivasan R
    Curr Med Chem; 2019; 26(13):2234-2242. PubMed ID: 28748768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computationally-guided optimization of small-molecule inhibitors of the Aurora A kinase-TPX2 protein-protein interaction.
    Cole DJ; Janecek M; Stokes JE; Rossmann M; Faver JC; McKenzie GJ; Venkitaraman AR; Hyvönen M; Spring DR; Huggins DJ; Jorgensen WL
    Chem Commun (Camb); 2017 Aug; 53(67):9372-9375. PubMed ID: 28787041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of small molecule inhibitors of the Aurora-A/TPX2 complex.
    Asteriti IA; Daidone F; Colotti G; Rinaldo S; Lavia P; Guarguaglini G; Paiardini A
    Oncotarget; 2017 May; 8(19):32117-32133. PubMed ID: 28389630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the design of allosteric inhibitors of the Aurora kinase A enzyme in the cancer chemotherapy.
    de Souza VB; Kawano DF
    Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129448. PubMed ID: 31676293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.
    McIntyre PJ; Collins PM; Vrzal L; Birchall K; Arnold LH; Mpamhanga C; Coombs PJ; Burgess SG; Richards MW; Winter A; Veverka V; Delft FV; Merritt A; Bayliss R
    ACS Chem Biol; 2017 Nov; 12(11):2906-2914. PubMed ID: 29045126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A TPX2 Proteomimetic Has Enhanced Affinity for Aurora-A Due to Hydrocarbon Stapling of a Helix.
    Rennie YK; McIntyre PJ; Akindele T; Bayliss R; Jamieson AG
    ACS Chem Biol; 2016 Dec; 11(12):3383-3390. PubMed ID: 27775325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SERS and MD simulation studies of a kinase inhibitor demonstrate the emergence of a potential drug discovery tool.
    Karthigeyan D; Siddhanta S; Kishore AH; Perumal SS; Ågren H; Sudevan S; Bhat AV; Balasubramanyam K; Subbegowda RK; Kundu TK; Narayana C
    Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10416-21. PubMed ID: 24972791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.
    Janeček M; Rossmann M; Sharma P; Emery A; Huggins DJ; Stockwell SR; Stokes JE; Tan YS; Almeida EG; Hardwick B; Narvaez AJ; Hyvönen M; Spring DR; McKenzie GJ; Venkitaraman AR
    Sci Rep; 2016 Jun; 6():28528. PubMed ID: 27339427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of AuroraA-TPX2 by novel natural inhibitors: molecular dynamics-based mechanistic analysis.
    Gupta A; Jain R; Wahi D; Goyal S; Jamal S; Grover A
    J Recept Signal Transduct Res; 2015; 35(6):626-33. PubMed ID: 26390942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2.
    Zorba A; Buosi V; Kutter S; Kern N; Pontiggia F; Cho YJ; Kern D
    Elife; 2014 May; 3():e02667. PubMed ID: 24867643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states.
    Lake EW; Muretta JM; Thompson AR; Rasmussen DM; Majumdar A; Faber EB; Ruff EF; Thomas DD; Levinson NM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11894-E11903. PubMed ID: 30518564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.
    Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS
    Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Aurora A-TPX2 Interaction Inhibitors Have
    Stockwell SR; Scott DE; Fischer G; Guarino E; Rooney TPC; Feng TS; Moschetti T; Srinivasan R; Alza E; Asteian A; Dagostin C; Alcaide A; Rocaboy M; Blaszczyk B; Higueruelo A; Wang X; Rossmann M; Perrior TR; Blundell TL; Spring DR; McKenzie G; Abell C; Skidmore J; Venkitaraman AR; Hyvönen M
    J Med Chem; 2024 Sep; 67(17):15521-15536. PubMed ID: 39190548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of TPX2 to Aurora A alters substrate and inhibitor interactions.
    Anderson K; Yang J; Koretke K; Nurse K; Calamari A; Kirkpatrick RB; Patrick D; Silva D; Tummino PJ; Copeland RA; Lai Z
    Biochemistry; 2007 Sep; 46(36):10287-95. PubMed ID: 17705509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching Aurora-A kinase on and off at an allosteric site.
    Bayliss R; Burgess SG; McIntyre PJ
    FEBS J; 2017 Sep; 284(18):2947-2954. PubMed ID: 28342286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of N-benzylbenzamide-based allosteric inhibitors of Aurora kinase A.
    Lee H; Kim E; Hwang N; Yoo J; Nam Y; Hwang I; Park JG; Park SE; Chung KS; Won Chung H; Song C; Ji MJ; Park HM; Lee IK; Lee KT; Joo Roh E; Hur W
    Bioorg Med Chem; 2024 Mar; 102():117658. PubMed ID: 38460487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of kinase-inhibitor interactions by auxiliary protein binding: crystallography studies on Aurora A interactions with VX-680 and with TPX2.
    Zhao B; Smallwood A; Yang J; Koretke K; Nurse K; Calamari A; Kirkpatrick RB; Lai Z
    Protein Sci; 2008 Oct; 17(10):1791-7. PubMed ID: 18662907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues in interpreting the in vivo activity of Aurora-A.
    Shagisultanova E; Dunbrack RL; Golemis EA
    Expert Opin Ther Targets; 2015 Feb; 19(2):187-200. PubMed ID: 25384454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain.
    Burgess SG; Oleksy A; Cavazza T; Richards MW; Vernos I; Matthews D; Bayliss R
    Open Biol; 2016 Jul; 6(7):. PubMed ID: 27411893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of specific binding between Aurora A and TPX2 by molecular dynamics simulations.
    Cheng Y; Zhang F; Chen Q; Gao J; Cui W; Ji M; Tung CH
    J Chem Inf Model; 2011 Oct; 51(10):2626-35. PubMed ID: 21919471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.